Final answer:
Sublingual nitroglycerin tablets can be dispensed in a non-child-resistant package according to the Poison Prevention Packaging Act of 1970, as they are used in emergency situations for angina pectoris where immediate access is essential.
Step-by-step explanation:
According to the Poison Prevention Packaging Act of 1970, certain medications may be dispensed in non-child-resistant packaging if the use of such packaging might delay access in an emergency situation where timeliness is crucial for the medication's effectiveness. One example of such an exception is for sublingual nitroglycerin tablets. This medication is used during emergency situations to manage acute angina pectoris, and immediate access can be life-saving. Therefore, in an outpatient setting, sublingual nitroglycerin tablets can be dispensed in a non-child-resistant package, ensuring that the medication can be accessed quickly by patients experiencing heart-related chest pain. In contrast, medications such as sublingual or extended-release nitrofurantoin tablets are typically used for conditions where immediate access is not critical, so these would not fall under exceptions permitting non-child-resistant packaging.